MedPacto Inc

235980 · KQ · Healthcare / Biotechnology

4,260.00KRW+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close4,260.00

Open4,485.00

Day Range4,215.00 – 4,720.00

52-Week Range2,235.00 – 8,650.00

Volume1.06M

Market Cap102.48B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield0.00%

Beta0.20

50-Day Avg2,734.90

200-Day Avg4,483.40

About

MedPacto, Inc. engages in the development and sale of marker-based new drugs in South Korea. MedPacto, Inc. was established in 2013 and is based in Seoul, South Korea.

Company Details

SectorHealthcare
IndustryBiotechnology
CEODr. Jungwon Woo Ph.D.
Employees56
HeadquartersBorim Building, Seoul, South Korea, Korea
Websitehttps://www.medpacto.com

Leadership

Dr. Seong-Jin Kim Ph.D.Founder, Chairman & CTO
Dr. Jungwon Woo Ph.D.President & CEO
Mr. Ki Baik Hahm M.D., Ph.D.Executive Vice President of R&D
Mr. Sunjin Hwang M.D.Chief Medical Officer
Dr. Timothy R. AllenExecutive Vice President of Clinical Development at MedPacto Therapeutics - U.S.

Financials

Income Statement

Currency: KRW	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	0	0	0	0	0	0	0	0	3.90B
Cost of Revenue	0	0	0	0	0	0	0	0	3.51B
Gross Profit	0	0	0	0	0	0	0	0	385.16M
Gross Margin	-	-	-	-	-	-	-	-	9.88%
Operating Expense	3.23B	10.16B	13.24B	27.80B	29.46B	37.19B	35.36B	21.82B	14.40B
Operating Income	-3.23B	-10.16B	-13.24B	-27.80B	-29.46B	-37.19B	-35.36B	-21.82B	-14.02B
Operating Margin	-	-	-	-	-	-	-	-	-359.59%
EBITDA	-	-	-	-	-	-24.27B	-33.00B	-18.51B	-11.54B
EBITDA Margin	-	-	-	-	-	-	-	-	-295.95%
Net Income	-3.47B	-37.58B	-13.52B	-25.35B	-17.04B	-35.75B	-35.32B	-20.14B	-12.81B
Net Income Margin	-	-	-	-	-	-	-	-	-328.61%
R&D	-	-	-	23.96B	24.55B	31.92B	24.16B	18.02B	10.14B
R&D as % of Total Revenue	-	-	-	-	-	-	-	-	260.04%
Interest Expense	0	0	0	31.27M	7.77B	9.62B	493.23M	91.94M	117.31M
Interest Expense % of Total Revenue	-	-	-	-	-	-	-	-	3.01%

Balance Sheet

Currency: KRW	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	1.33B	31.82B	80.70B	58.50B	133.35B	107.69B	80.47B	60.79B	48.66B
Total Liabilities	11.63B	27.24B	2.00B	2.75B	89.80B	75.36B	9.57B	3.04B	2.68B
Total Equity	-10.29B	4.58B	78.69B	55.74B	43.54B	32.32B	70.91B	57.74B	45.98B
Cash	19.24M	301.10M	173.17M	2.69B	1.29B	359.85M	72.60B	15.01B	12.00B
Total Debt	4.38B	1.95B	451.64M	159.49M	-	-	-	-	-
Net Debt	-	-	173.72M	-	49.41B	59.90B	-	-	-

Cash Flow

Currency: KRW	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-2.69B	-8.12B	-15.20B	-23.38B	-25.15B	-29.61B	-26.30B	-16.56B	-13.39B
Investing Cash Flow	131.78M	-30.31B	-45.92B	26.13B	-77.77B	25.76B	96.53B	-40.24B	-
Financing Cash Flow	2.57B	38.72B	61.00B	-60.40M	101.52B	2.90B	2.01B	-843.82M	-
Capital Expenditure	81.41M	754.51M	2.58B	718.08M	756.56M	877.63M	172.91M	322.67M	243.08M
Free Cash Flow	-	-	-16.06B	-24.19B	-26.06B	-30.54B	-26.47B	-16.88B	-13.63B
FCF to OCF	-	-	105.64%	103.47%	103.61%	103.12%	100.66%	101.95%	101.82%

Earnings

Report Date	Mar 10, 2020	May 13, 2020	Aug 13, 2020	Nov 12, 2020	Feb 15, 2021	May 14, 2021	Aug 12, 2021	Nov 15, 2021	Feb 10, 2022	May 13, 2022	Aug 12, 2022	Nov 11, 2022	Feb 10, 2023	May 12, 2023	Aug 10, 2023	Nov 3, 2023	Mar 20, 2024	May 16, 2024	Aug 9, 2024	Nov 4, 2024	Mar 18, 2025	May 15, 2025	Aug 12, 2025	Nov 12, 2025	Mar 18, 2026	May 13, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	-133.15	-413.00	-246.00	-402.00	-393.18	-60.00	-85.00	-322.00	-364.69	-225.00	-381.00	-397.08	-698.15	-662.75	-358.79	-257.75	-349.31	-276.31	-139.43	-52.22	-130.07	-100.02	-66.13	-131.87	-77.77	-109.70	-93.18
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	-

Key Statistics & Ratios

Market Cap102.48B

Enterprise Value62.13B

Trailing P/E0.00

Forward P/E0.00

Price / Sales20.52

Price / Book2.43

Revenue (TTM)4.99B

Gross Profit (TTM)416.80M

EBITDA-14.35B

Profit Margin-283.09%

Operating Margin-341.99%

Return on Equity-30.76%

Return on Assets-19.73%

Shares Outstanding34.28M

Shares Float25.23M

Beta0.20

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Stock Splits

Oct 4, 20232237:1910
May 13, 20202:1